CARDLYTICS, INC. (CDLX) Spending and interest coverage
- R&D / revenue · 12 months: Value 18.69%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 11.31%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 18.69% | Research and development expense / revenue. Period ending 2026-06-30. $31.59M ÷ $169.05M × 100 ≈ 18.69% |
| Stock-based compensation / revenue · 12 months | 11.31% | Share-based compensation / revenue. Period ending 2026-06-30. $19.12M ÷ $169.05M × 100 ≈ 11.31% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 31.59M USD | Research and Development Expense |
| Revenue | 169.05M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 19.12M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -94.85M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $31.59M | $169.05M | $19.12M | $-94.85M | (m) | 18.69% | 11.31% | (m) | (m) |
| 2026-03-31 | $35.92M | $190.21M | $24.26M | $-98.97M | (m) | 18.88% | 12.76% | (m) | (m) |
| 2025-12-31 | $39.77M | $212.33M | $28.13M | $-101.82M | (m) | 18.73% | 13.25% | (m) | (m) |
| 2025-09-30 | $41.70M | $229.71M | $31.29M | $-104.03M | (m) | 18.15% | 13.62% | (m) | (m) |
| 2025-06-30 | $46.09M | $243.85M | $32.93M | $-183.73M | (m) | 18.90% | 13.51% | (m) | (m) |
| 2025-03-31 | $48.27M | $249.82M | $38.08M | $-186.75M | (m) | 19.32% | 15.24% | (m) | (m) |
| 2024-12-31 | $49.61M | $255.61M | $40.37M | $-195.50M | (m) | 19.41% | 15.79% | (m) | (m) |
| 2024-09-30 | $52.22M | $269.95M | $42.72M | $-290.11M | (m) | 19.35% | 15.82% | (m) | (m) |
| 2024-06-30 | $51.46M | $281.90M | $44.90M | $-162.21M | (m) | 18.25% | 15.93% | (m) | (m) |
| 2024-03-31 | $52.84M | $288.63M | $44.00M | $-170.72M | (m) | 18.31% | 15.24% | (m) | (m) |
| 2023-12-31 | $51.35M | $285.43M | $40.98M | $-135.67M | (m) | 17.99% | 14.36% | (m) | (m) |
| 2023-09-30 | $53.64M | $279.47M | $42.45M | $-415.38M | (m) | 19.19% | 15.19% | (m) | (m) |
| 2023-06-30 | $54.97M | $273.69M | $37.97M | $-383.21M | (m) | 20.09% | 13.87% | (m) | (m) |
| 2023-03-31 | $53.71M | $272.23M | $39.07M | $-481.21M | (m) | 19.73% | 14.35% | (m) | (m) |
| 2022-12-31 | $54.44M | $277.19M | $44.69M | $-457.78M | (m) | 19.64% | 16.12% | (m) | (m) |
| 2022-09-30 | $51.45M | $287.22M | $45.04M | $-91.55M | (m) | 17.91% | 15.68% | (m) | (m) |
| 2022-06-30 | $48.82M | $282.01M | $56.11M | $-142.87M | (m) | 17.31% | 19.89% | (m) | (m) |
| 2022-03-31 | $44.18M | $269.51M | $56.60M | $-64.77M | (m) | 16.39% | 21.00% | (m) | (m) |
| 2021-12-31 | $38.10M | $258.75M | $50.26M | $-122.60M | (m) | 14.73% | 19.43% | (m) | (m) |
| 2021-09-30 | $31.38M | $239.15M | $45.00M | $-112.31M | (m) | 13.12% | 18.82% | (m) | (m) |
| 2021-06-30 | $24.87M | $223.15M | $39.75M | $-87.17M | (m) | 11.14% | 17.81% | (m) | (m) |
| 2021-03-31 | $19.90M | $194.61M | $35.52M | $-64.16M | (m) | 10.22% | 18.25% | (m) | (m) |
| 2020-12-31 | $17.53M | $186.89M | $32.40M | $-53.92M | (m) | 9.38% | 17.33% | (m) | (m) |
| 2020-09-30 | $15.40M | $189.10M | $28.40M | $-46.55M | (m) | 8.14% | 15.02% | (m) | (m) |
| 2020-06-30 | $13.79M | $199.44M | $24.30M | $-37.01M | (m) | 6.92% | 12.19% | (m) | (m) |
| 2020-03-31 | $12.61M | $219.95M | $18.27M | $-22.75M | (m) | 5.73% | 8.31% | (m) | (m) |
| 2019-12-31 | $11.70M | $210.43M | $15.85M | $-17.32M | (m) | 5.56% | 7.53% | (m) | (m) |
| 2019-09-30 | $12.51M | $188.96M | $22.09M | $-29.39M | (m) | 6.62% | 11.69% | (m) | (m) |
| 2019-06-30 | $13.59M | $167.12M | $20.32M | $-31.45M | (m) | 8.13% | 12.16% | (m) | (m) |
| 2019-03-31 | $15.69M | $153.96M | $25.60M | $-37.60M | (m) | 10.19% | 16.63% | (m) | (m) |
| 2018-12-31 | $16.21M | $150.68M | $26.79M | $-40.92M | (m) | 10.76% | 17.78% | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $12.15M | $130.37M | $5.15M | $-17.10M | (m) | 9.32% | 3.95% | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $13.90M | $112.82M | $3.45M | $-56.23M | (m) | 12.32% | 3.06% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM) | United States | $0.016B | -4.22 |
| Global Interactive Technologies, Inc. (GITS) | $0.008B | ||
| TaoWeave, Inc. (TWAV) | United States | $0.006B | |
| ZW Data Action Technologies Inc. (CNET) | $0.005B | -5.46 | |
| AIRWA INC. (YYAI) | United States | $0.004B | -101.45 |
| Teads Holding Co. (TEAD) | United States | $0.045B | -0.14 |
| Professional Diversity Network, Inc. (IPDN) | United States | $0.060B | |
| PodcastOne, Inc. (PODC) | United States | $0.068B | -42.98 |
| Eva Live Inc (GOAI) | United States | $0.083B | |
| Health Catalyst, Inc. (HCAT) | United States | $0.132B | -0.56 |